FLOODLIGHT: smartphone-based self-monitoring is accepted by patients and provides meaningful, continuous digital outcomes augmenting conventional in-clinic multiple sclerosis measures

被引：0

作者：

Montalban, X. ^{[1
,2
]}

Mulero, P. ^{[2
]}

Midaglia, L. ^{[2
]}

Graves, J. ^{[3
]}

Hauser, S. L. ^{[3
]}

Julian, L. ^{[4
]}

Baker, M. ^{[5
]}

Schadrack, J. ^{[5
]}

Gossens, C. ^{[5
]}

Scotland, A. ^{[5
]}

Lipsmeier, F. ^{[5
]}

Bernasconi, C. ^{[5
]}

Belachew, S. ^{[5
]}

Lindemann, M. ^{[5
,6
]}

机构：

[1] Univ Toronto, Div Neurol, Toronto, ON, Canada

[2] Vall dHebron Univ Hosp, Barcelona, Spain

[3] Univ Calif San Francisco, San Francisco, CA 94143 USA

[4] Genentech Inc, San Francisco, CA 94080 USA

[5] F Hoffmann La Roche Ltd, Basel, Switzerland

[6] Baden Wuerttemberg Cooperat State Univ, Lorrach, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P624

引用

页码：310 / 311

页数：2